96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

24 trials found

diseases per page:

Showing 1 to 10 of 24 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001866-14-CZ (EUCTR)	04/01/2023	15/06/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumabin Participants With Moderately to Severely Ac ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Russian Federation;Israel;United Kingdom ...
2	EUCTR2019-001866-14-IT (EUCTR)	21/12/2021	12/10/2021	Open-label Extension Study of Brazikumab in Crohn's Disease	An Open-label, Long-term Extension Study of Brazikumabin Participants With Moderately to Severely Ac ...	Moderately to Severely Active Crohn's Disease. MedDRA version: 20.0;Level: LLT;Classification code 1 ...	Product Name: Brazikumab Product Code: [MEDI2070] INN or Proposed INN: ( L ) ASCORBATO DI CALCIO Other ...	ASTRAZENECA AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
3	EUCTR2018-004346-42-SK (EUCTR)	23/11/2021	09/06/2021	A Study of the Efficacy and Safety of Brazikumabin Participants with Moderately to Severely Active C ...	A 52-Week, Multicenter, Randomized, Double-blind, Placebo and Active-Controlled, Operationally Seaml ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	553	Phase 2;Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
4	EUCTR2019-001866-14-HU (EUCTR)	09/11/2021	02/08/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumabin Participants With Moderately to Severely Ac ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
5	EUCTR2019-001866-14-ES (EUCTR)	27/10/2021	30/09/2020	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumabin Participants with Moderately to Severely Ac ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 3	China;Korea, Republic of;United States;Taiwan;Spain;Ukraine;Austria;Russian Federation;Israel;United ...
6	EUCTR2018-004346-42-HU (EUCTR)	15/10/2021	31/01/2020	A Study of the Efficacy and Safety of Brazikumabin Participants with Moderately to Severely Active C ...	A 52-Week, Multicenter, Randomized, Double-blind, Placebo and Active-Controlled, Operationally Seaml ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	553	Phase 2;Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
7	EUCTR2019-001866-14-PL (EUCTR)	27/09/2021	08/09/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumabin Participants With Moderately to Severely Ac ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
8	EUCTR2019-001866-14-DE (EUCTR)	10/09/2021	11/06/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumabin Participants With Moderately to Severely Ac ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	United Kingdom;Italy;India;France;Czech Republic;Hungary;Canada;Poland;South Africa;Germany;Korea, R ...
9	EUCTR2019-001866-14-AT (EUCTR)	25/08/2021	25/06/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumabin Participants With Moderately to Severely Ac ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
10	EUCTR2018-004346-42-IT (EUCTR)	03/09/2020	24/05/2021	An Active and Placebo-Controlled Study of Brazikumabin Participants With Moderately to Severely Acti ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma INN or Propo ...	ALLERGAN LIMITED	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Czechia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;France;Cz ...

First Previous1 2 3Next Last